SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 170 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$326,000
-38.1%
6,291
-15.0%
0.01%
-40.0%
Q1 2022$527,000
+3.9%
7,399
+9.1%
0.01%
-23.1%
Q4 2021$507,000
+113.9%
6,779
+62.6%
0.01%
+225.0%
Q3 2021$237,000
-37.8%
4,169
-51.9%
0.00%
-42.9%
Q2 2021$381,000
+28.3%
8,664
+44.1%
0.01%
+40.0%
Q1 2021$297,000
-61.1%
6,012
-64.0%
0.01%
-78.3%
Q3 2020$764,000
-30.5%
16,698
-23.8%
0.02%
-56.6%
Q2 2020$1,100,00021,9160.05%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 735,103$8,2113.02%
BRAIDWELL LP 1,038,310$11,597,9230.37%
ARMISTICE CAPITAL, LLC 2,100,000$23,457,0000.36%
FARALLON CAPITAL MANAGEMENT LLC 1,875,000$20,943,7500.10%
PDT Partners, LLC 67,318$751,9420.10%
Virtus ETF Advisers LLC 12,784$142,7970.09%
Portland Global Advisors LLC 34,175$3820.06%
XTX Topco Ltd 27,222$304,0700.05%
Trexquant Investment LP 132,561$1,480,7060.04%
SHERBROOKE PARK ADVISERS LLC 10,100$112,8170.04%
View complete list of ENANTA PHARMACEUTICALS INC shareholders